Clinical Trial Update: Safety Study of ProQuad® rHA in Infants (V221-037) [Phase 3]

View source ↗

Summary

Phase 3 safety study of ProQuad rHA in infants completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• ProQuad rHA

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Measles, Mumps | Phase 3 | Status: COMPLETED | Results posted: 2017-10-17